Body composition assessment for the definition of cardiometabolic risk

Journal of Endocrinological Investigation

Volumn 36, Issue 7, 2013, Pages 537-543

  Amato, M C ^a   Guarnotta, V ^a   Giordano, C ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

BMI; Cardiometabolic risk; Obesity; Visceral adiposity index; Waist circumference

Indexed keywords

ABDOMINAL OBESITY; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INSULIN SENSITIVITY; LEAN BODY WEIGHT; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WAIST TO HEIGHT RATIO;

ABDOMINAL FAT; ADULT; AGED; BODY FAT DISTRIBUTION; BODY HEIGHT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MAGNETIC RESONANCE IMAGING; MALE; MATHEMATICAL CONCEPTS; MIDDLE AGED; OBESITY; RISK; ROC CURVE; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84881413140     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8943     Document Type: Review

References (71)

1. Després J, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444: 881-7.
2. Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 2000, 23: 465-71.
3. CefaluW, Wang ZM, Webel S, et al. Contribution of visceral fat mass to the insulin resistance of aging. Metabolism 1995, 44: 954-9.
4. Hayashi T, Boyko EJ, Leonetti DL, et al. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med 2004, 140: 992-1000.
5. Kuk JL, Katzmarzyk PT, Nichaman MZ, Chruch TS, Blair SN, Ross R. Visceral fat is an independent predictor of all-cause mortality in men. Obesity 2006, 14: 336-41.
6. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294: 2166-70.
7. Misra A, Vikram NK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition 2003, 19: 457-66.
8. Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino L, DeFronzo RA. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2002, 283: E1135-43.
9. Montague CT, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 2000, 49: 883-8.
10. Nicklas B, Penninx B, Cesari M, Kritchevsky S, Newman A, Kanaya A. Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study. Am J Epidemiol 2004, 160: 741-9.
11. Motoshima H, Wu X, Sinha MK, et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 2002, 87: 5662-7.
12. Nguyen-Duy TB, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol Metab 2003, 284: E1065-71.
13. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000, 21: 697-738.
14. Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF. Depotspecific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 2002, 34: 616-21.
15. Freedland E. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond) 2004, 1: 12.
16. Shen W, Wang Z, Punyanita M, et al. Adipose tissue quantification by imaging methods: a proposed classification. Obes Res 2003, 11: 5-16.
17. Mathieu P, Lemieux I, Després JP. Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther 2010, 87: 407-16.
18. Shen W, Liu H, Punyanitya M, Chen J, Heymsfield SB. Pediatric obesity phenotyping by magnetic resonance methods. Curr Opin Clin Nutr Metab Care 2005, 8: 595-601.
19. Hu HH, Nayak KS, Goran MI. Assessment of abdominal adipose tissue and organ fat content by magnetic resonance imaging. Obes Rev 2011, 12: e504-15.
20. Würslin C, Machann J, Rempp H, Claussen C, Yang B, Schick F. Topography mapping of whole body adipose tissue using a fully automated and standardized procedure. J Magn Reson Imaging 2010, 31: 430-9.
21. Kuk JL, Church TS, Blair SN, Ross R. Does measurement site for visceral and abdominal subcutaneous adipose tissue alter associations with the metabolic syndrome? Diabetes Care 2006, 29: 679-84.
22. Carr D, Utzschneider K, Hull R, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004, 53: 2087-94.
23. Shen W, Punyanitya M, Chen J et al. Visceral adipose tissue: relationships between single slice areas at different locations and obesity-related health risks. Int J Obes 2007, 31: 763-9.
24. Machann J, Thamer C, Schnoedt B et al. Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 2005, 21: 455-62.
25. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation fromskinfold thickness:measurements on 481men and women aged from 16 to 72 years. Br J Nutr 1974, 32: 77-97.
26. Nazare JA, Smith JD, Borel AL, et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity. Am J Clin Nutr 2012, 96: 714-26.
27. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 2000, 72: 694.
28. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. J Am Med Assoc 2005, 293: 1861-7.
29. Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006, 368: 666-78.
30. Franzosi MG. Should we continue to use BMI as a cardiovascular risk factor? Lancet 2006, 368: 624-5.
31. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364: 937-52.
32. Yusuf S, Hawken S, Ounpuu S et al. Obesity and the risk of myocardial infarction in 27.000 participants from 52 countries: a casecontrol study. Lancet 2005, 366: 1640-9.
33. Wang J, Thornton JC, Bari S et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr 2003, 77: 379-84.
34. National Institute of Health, National Heart, Lung, and Blood Institute in cooperation with The National Institute of Diabetes and Digestive and Kidney Diseases. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in the adults: the Evidence Report, NIH publication No 98-4083 September 1998.
35. Ross R, Berentzen T, Bradshaw AJ, et al. Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference? Obes Rev 2008, 9: 312-25.
36. Lee JS, Aoki K, Kawakubo K, Gunji A. A study on indicators of body fat distribution for screening for obesity. J Occup Health 1995, 37: 9-18.
37. Hsieh SD, Yoshinaga H. Abdominal fat distribution and coronary heart disease risk factors in men waist/height ratio as a simple and useful predictor. Int J Obes Relat Metab Disord 1995, 19: 585-9.
38. Ashwell M, Lejeune S, McPherson K. Ratio of waist circumference to height may be better indicator of need for weight management. Br Med J 1996, 312: 377.
39. Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr 2005, 56: 303-7.
40. Schneider HJ, Glaesmer H, Klotsche J et al. Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab 2007, 92: 589-94.
41. Freedman DS, Kahn HS, Mei Z et al. Relation of body mass index and waist-to-height ratio to cardiovascular disease risk factors in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr 2007, 86: 33-40.
42. Nambiar S, Truby H, Abbott RA, Davies PS. Validating the waist-height ratio and developing centiles for use amongst children and adolescents. Acta Paediatr 2009, 98: 148-52.
43. Ashwell M, Gibson S. Waist to height ratio is a simple and effective obesity screening tool for cardiovascular risk factors: analysis of data from the British National Diet and Nutrition Survey of adults aged 19 to 64 years. Obes Facts 2009, 2: 97-103.
44. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 2010, 23: 247-69.
45. Ashwell M, Cole TJ, Dixon AK. Ratio of waist circumference to height is strong predictor of intra-abdominal fat. Br Med J 1996, 313: 559-60.
46. Wu HY, Xu SY, Chen LL, Zhang HF. Waist to height ratio as a predictor of abdominal fat distribution in men. Chin J Physiol 2009, 52: 441-5.
47. Deurenberg P, Yap M. The assessment of obesity: methods for measuring body fat and global prevalence of obesity. Baillieres Best Pract Res Clin Endocrinol Metab 1999, 13: 1-11.
48. Pouliot, M.C., Despres, J.P., Lemieux, S. et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994, 73: 460-8.
49. Lee CMY, Huxley RR, Wildman RP, Woodward M. Indicators of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol 2008, 61: 646-53
50. Amato MC, Giordano C, Galia M, et al; AlkaMeSy Study Group. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 2010, 33: 920-2.
51. Petta S, Amato M, Cabibi D, et al. Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Hepatology 2010, 52: 1543-52.
52. Knowles KM, Paiva LL, Sanchez SE, et al.Waist circumference, body mass index, and other measures of adiposity in predicting cardiovascular disease risk factors among Peruvian adults. Int J Hypertens 2011, 24: 931402.
53. Amato MC, Verghi M, Galluzzo A, Giordano C. The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk. Hum Reprod 2011, 26: 1486-94.
54. Bozorgmanesh M, Hadaegh F, Azizi F. Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: type 2 diabetes. Lipids Health Dis 2011, 10: 88.
55. Amato MC, Giordano C, Pitrone M, Galluzzo A. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis 2011, 10: 183.
56. Petta S, Amato MC, Di Marco V, et al. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2012, 35: 238-47.
57. Musso G, Cassader M, Gambino R. Diagnostic accuracy of adipose insulin resistance index and visceral adiposity index for progressive liver histology and cardiovascular risk in nonalcoholic fatty liver disease. Hepatology 2012, 56: 788-9.
58. Musso G, Cassader M, De Michieli F, Rosina F, Orlandi F, Gambino R. Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism. Hepatology 2012, 56: 933-42.
59. Mohammadreza B, Farzad H, Davoud K, Prof AF. Prognostic significance of the Complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study. Cardiovasc Diabetol 2012, 11: 20.
60. Vongsuvanh R, George J, McLeod D, van der Poorten D. Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease. J Hepatol 2012, 57: 392-8.
61. Ciresi A, Amato MC, Pizzolanti G, Galluzzo CG. Visceral Adiposity Index Is Associated with Insulin Sensitivity and Adipocytokine Levels in Newly Diagnosed Acromegalic Patients. J Clin Endocrinol Metab 2012, 97: 2907-15.
62. Bouchard C. BMI, fat mass, abdominal adiposity and visceral fat: where is the 'beef'?. Int J Obes 2007, 31: 1552-3.
63. Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism 2001, 50: 1499-504.
64. Després JP. What is "metabolically healthy obesity"?: from epidemiology to pathophysiological insights. J Clin Endocrinol Metab 2012, 97: 2283-5.
65. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998, 47: 699-713.
66. Katsuki A, Sumida Y, Urakawa H, et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 2003, 26: 2341-4.
67. Newman AB, Lee JS, Visser M, et al. Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study. Am J Clin Nutr 2005, 82: 872-8.
68. Kim TN, Yang SJ, Yoo HJ, et al. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes 2009, 33: 885-92.
69. Abbatecola AM, Paolisso G, Fattoretti P, et al. Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction. J Nutr Health Aging 2011, 15: 890-5.
70. Kim TN, Park MS, Yang SJ, et al. Body size phenotypes and low muscle mass: The Korean Sarcopenic Obesity Study (KSOS). J Clin Endocrinol Metab 2013, 98: 811-7.
71. Bray GA. Don't throw the baby out with the bath water. Am J Clin Nutr 2004, 79: 347-9.